Myelodysplastic Syndromes in Older Adults: Treatment Options and Support Strategies

Thursday, May 03, 2018
More than 80% of patients diagnosed with myelodysplastic syndromes (MDS) are over 70 years of age. Care for these patients requires understanding the disease in the context of an older population, and tailoring approaches to both disease risk and patient suitability for therapy.

In this free continuing education series, Marlise R. Luskin, MD, MSCE and Ilene Galinsky BSN, MSN, NP-C will present current research and case examples. Treatment options and common experiences for older patients with MDS and their families will be discussed. CE Credit is available. See full webinar details for more information.

Webinar Details
•         Date: Tuesday, May 8, 2018
•         Time: 12:00 – 1:15 p.m. CDT
•         Speakers: 
                    Marlise R. Luskin, MD, MSCE, Dana-Farber Cancer Institute 
                    Ilene Galinsky BSN, MSN, NP-C, Dana-Farber Cancer Institute (DFCI)
                    and Brigham and Women’s Hospital (BWH)


Supported by the National Marrow Donor Program® (NMDP), Be The Match® and Aplastic Anemia and MDS International Foundation (AAMDSIF)
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.